Порівняння методів
Переглядайте обрані методи поруч; рядки з відмінностями підсвічено.
| Надійна оцінка контрфактичного впливу× | Зіставлення за показником схильності× | |
|---|---|---|
| Галузь≠ | Причинно-наслідковий висновок | Статистика досліджень |
| Родина≠ | Regression model | Process / pipeline |
| Рік появи≠ | 2010s | 1983 |
| Автор методу≠ | European Commission evaluation community; Pellegrini, Ferrara and colleagues | Paul Rosenbaum and Donald Rubin |
| Тип≠ | Robustness-validated causal evaluation | Method |
| Основоположне джерело≠ | Bia, M., Flores, C. A., Flores-Lagunes, A., & Mattei, A. (2014). A Stata package for the application of semiparametric estimators of dose–response functions. Stata Journal, 14(3), 580–604. link ↗ | Rosenbaum, P. R., & Rubin, D. B. (1983). The central role of the propensity score in observational studies for causal effects. Biometrika, 70(1), 41–55. DOI ↗ |
| Інші назви≠ | Robust CIE, Sensitivity-checked CIE, Multi-method counterfactual evaluation, Robustness-validated impact evaluation | PSM, propensity score weighting, covariate balance |
| Пов'язані≠ | 5 | 3 |
| Підсумок≠ | Robust Counterfactual Impact Evaluation (Robust CIE) strengthens causal impact estimates by combining multiple quasi-experimental estimators, placebo tests, and formal sensitivity analyses. Rather than relying on a single method, it cross-validates findings across approaches — such as matching, difference-in-differences, and regression discontinuity — to ensure that conclusions do not depend on any single methodological choice. | Propensity score matching (PSM) is a method for reducing confounding bias in observational studies by balancing baseline characteristics between treatment groups, simulating randomization. Developed by Rosenbaum and Rubin (1983), it estimates the probability of receiving treatment given observed covariates, then matches or weights treated and control individuals with similar treatment probabilities. Widely used in medicine, epidemiology, and policy evaluation when randomized trials are infeasible or unethical, enabling estimation of treatment effects while controlling for selection bias. |
| ScholarGateНабір даних ↗ |
|
|